United States· US:69097-686_01ca8568-cd52-42e0-87b8-2eea35a77364
TAVABOROLE
A tavaborole product containing tavaborole, registered in United States by Cipla USA Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TAVABOROLE
- Manufacturer
- Cipla USA Inc.
- Country
- United States (US)
- ATC code
- D01AE24
- ATC class
- Tavaborole
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1169097-686-37
- ndc1169097686371 BOTTLE, WITH APPLICATOR in 1 CARTON (69097-686-37) / 10 mL in 1 BOTTLE, WITH APPLICATOR
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D01AE24
Tavaborole, as other registers publish it.
- United StatestavaboroleMayne Pharma Commercial LLC
- United StatesTavaboroleChartwell RX, LLC
- United StatesTavaboroleAlembic Pharmaceuticals Inc.
- United StatesTavaboroleEncube Ethicals, Inc.
- United StatesTavaboroleViona Pharmaceuticals Inc
- United StatesTavaboroleZydus Lifesciences Limited
- United StatesTavaboroleAmneal Pharmaceuticals NY LLC
- United StatesTavaboroleAlembic Pharmaceuticals Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/89986bd4-5b5d-4427-8980-c316fdedd4ee GET /v1/drugs/89986bd4-5b5d-4427-8980-c316fdedd4ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "43.5",
"substance": "TAVABOROLE",
"productndc": "69097-686",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA212224",
"marketing_category": "ANDA"
}See everything about tavaborole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.